Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Targeting tumors: Ion beam accelerators take aim at cancer

12.02.2014
AAAS symposium and press briefing to explore the physics, biology, and clinical use of advanced particle therapy cancer treatments and related economic and ethical issues

EVENT: Advances in the design and operation of particle accelerators built for basic physics research are leading to the rapid evolution of machines that deliver cancer-killing beams. Hear about the latest developments and challenges in this field from a physicist, a radiobiologist, and a clinical oncologist, and participate in a discussion about cost, access, and ethics at a symposium organized by the U.S. Department of Energy's Brookhaven National Laboratory ("Targeting Tumors: Ion Beam Accelerators Take Aim at Cancer") and at a related press briefing--both to be held at the 2014 meeting of the American Association for the Advancement of Science.

WHEN: Sunday, February 16, 2014, 8:00 a.m. Central Time (symposium) and 11:00 a.m. (press briefing)

WHERE: Symposium: Hyatt Regency Chicago, Grand Ballroom A; Press Briefing: Swissotel, AAAS briefing room, adjacent to the newsroom, second floor.

WEBCAST: For reporters unable to attend the meeting, the press briefing portion will be webcast live and archived in the AAAS meeting newsroom.

DETAILS: As particle accelerator technology has been incorporated into the clinical practice of treating cancer, the trend has been toward less expensive, more versatile particle beam delivery systems, designed for improved efficacy and greater access for cancer patients around the world. Proton and ion beams are particularly attractive in treating cancer because they deposit most of their energy where the beam stops (i.e., in the tumor) rather than in the tissue through which they travel. As a result, particle beams can deliver cell-killing energy with extreme precision, allowing less damage to adjacent healthy tissue than conventional x-ray or electron radiation treatments.

Protons have been in use for some time at several facilities in the U.S. Beams of heavier ions such as carbon offer promise of even greater efficacy, based on the physics and expected radiobiological effects, as well as on preliminary evidence from facilities operating in Europe and Japan. There are currently no carbon therapy cancer treatment facilities operating in the U.S., and while experience from Europe and Asia suggests that the cost of building one would be considerable, the U.S. National Cancer Institute recently announced a funding opportunity to encourage and support plans for a center for particle beam radiation therapy research.

This symposium and press briefing will explore the scientific rationale behind hadron beam therapy (using protons and heavier ions such as carbon) from the perspectives of a physicist who designs state-of-the-art particle accelerators, a radiobiologist exploring how those particle beams affect cells and tumors, and a radiation oncologist in clinical practice. The session will also address the questions of how to test the relative efficacy of hadron therapy versus conventional radiation treatment and ethical issues related to clinical trials, how to leverage scientific expertise to bring advances driven by basic research to the benefit of society at large, and potential ways to increase treatment access for patients through cost-saving accelerator designs.

SPEAKERS

Stephen Peggs, Physicist, Brookhaven National Laboratory, Adjunct Professor, Stony Brook University (Advances in Accelerator Science Deliver Precision Beams for Cancer Therapy)

Kathryn Held, Radiation Biologist, Associate Professor of Radiation Oncology, Harvard Medical School; associate radiation biologist, Massachusetts General Hospital (Charged Particles for Cancer Treatment: The Benefits of Ions over Photons)

Hak Choy, Chair, Department of Radiation Oncology at the University of Texas Southwestern Medical Center (The Clinical Perspective: Does Proton/Ion Beam Therapy Work?)

Discussant: Ken Peach, Professor, Particle Therapy Cancer Research Institute at Oxford Martin School, Oxford University

Moderator: James Deye, Program Director, Division of Cancer Treatment and Diagnosis, Radiation Research Program, National Cancer Institute

This session was organized by Karen McNulty Walsh, Media & Communications Office, Brookhaven National Laboratory with Co-Organizers Stephen Peggs, Physicist, Brookhaven National Laboratory, and Eric Colby, Office of Science, U.S. Department of Energy.

For more details, including links to talk summaries, see: http://aaas.confex.com/aaas/2014/webprogram/Session6784.html

Brookhaven Lab's role in this research and this symposium is funded by the DOE Office of Science.

DOE's Office of Science is the single largest supporter of basic research in the physical sciences in the United States, and is working to address some of the most pressing challenges of our time. For more information, please visit science.energy.gov.

One of ten national laboratories overseen and primarily funded by the Office of Science of the U.S. Department of Energy (DOE), Brookhaven National Laboratory conducts research in the physical, biomedical, and environmental sciences, as well as in energy technologies and national security. Brookhaven Lab also builds and operates major scientific facilities available to university, industry and government researchers. Brookhaven is operated and managed for DOE's Office of Science by Brookhaven Science Associates, a limited-liability company founded by the Research Foundation for the State University of New York on behalf of Stony Brook University, the largest academic user of Laboratory facilities, and Battelle, a nonprofit applied science and technology organization.

Karen McNulty Walsh | EurekAlert!
Further information:
http://www.bnl.gov

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Surfing a wake of light

Researchers observe and control light wakes for the first time

When a duck paddles across a pond or a supersonic plane flies through the sky, it leaves a wake in its path. Wakes occur whenever something is traveling...

Im Focus: Light-induced Magnetic Waves in Materials Engineered at the Atomic Scale

Researchers explore ultrafast control of magnetism across interfaces: A new study discovers how the sudden excitation of lattice vibrations in a crystal can trigger a change of the magnetic properties of an atomically-thin layer that lies on its surface.

A research team, led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter at CFEL in Hamburg, the University of Oxford, and the...

Im Focus: Viaducts with wind turbines, the new renewable energy source

Wind turbines could be installed under some of the biggest bridges on the road network to produce electricity. So it is confirmed by calculations carried out by a European researchers team, that have taken a viaduct in the Canary Islands as a reference. This concept could be applied in heavily built-up territories or natural areas with new constructions limitations.

The Juncal Viaduct, in Gran Canaria, has served as a reference for Spanish and British researchers to verify that the wind blowing between the pillars on this...

Im Focus: X-rays and electrons join forces to map catalytic reactions in real-time

New technique combines electron microscopy and synchrotron X-rays to track chemical reactions under real operating conditions

A new technique pioneered at the U.S. Department of Energy's Brookhaven National Laboratory reveals atomic-scale changes during catalytic reactions in real...

Im Focus: Iron: A biological element?

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and a half billion years ago.

Think of an object made of iron: An I-beam, a car frame, a nail. Now imagine that half of the iron in that object owes its existence to bacteria living two and...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

World Conference on Regenerative Medicine in Leipzig: Last chance to submit abstracts until 2 July

25.06.2015 | Event News

World Conference on Regenerative Medicine: Abstract Submission has been extended to 24 June

16.06.2015 | Event News

MUSE hosting Europe’s largest science communication conference

11.06.2015 | Event News

 
Latest News

Down to the quantum dot

07.07.2015 | Physics and Astronomy

Tundra study uncovers impact of climate warming in the Arctic

07.07.2015 | Earth Sciences

Transition from 3 to 2 dimensions increases conduction, MIPT scientists discover

07.07.2015 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>